- Home
- LRMR vs MUE Comparison
LRMR vs MUE Comparison
Compare LRMR & MUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- MUE
- Stock Information
- Founded
- LRMR N/A
- MUE 1999
- Country
- LRMR United States
- MUE United States
- Employees
- LRMR N/A
- MUE N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- MUE Investment Bankers/Brokers/Service
- Sector
- LRMR Health Care
- MUE Finance
- Exchange
- LRMR Nasdaq
- MUE Nasdaq
- Market Cap
- LRMR 183.8M
- MUE 210.6M
- IPO Year
- LRMR N/A
- MUE N/A
- Fundamental
- Price
- LRMR $2.18
- MUE $9.49
- Analyst Decision
- LRMR Strong Buy
- MUE
- Analyst Count
- LRMR 8
- MUE 0
- Target Price
- LRMR $19.63
- MUE N/A
- AVG Volume (30 Days)
- LRMR 1.3M
- MUE 62.6K
- Earning Date
- LRMR 04-30-2025
- MUE 01-01-0001
- Dividend Yield
- LRMR N/A
- MUE 4.09%
- EPS Growth
- LRMR N/A
- MUE N/A
- EPS
- LRMR N/A
- MUE N/A
- Revenue
- LRMR N/A
- MUE N/A
- Revenue This Year
- LRMR N/A
- MUE N/A
- Revenue Next Year
- LRMR N/A
- MUE N/A
- P/E Ratio
- LRMR N/A
- MUE N/A
- Revenue Growth
- LRMR N/A
- MUE N/A
- 52 Week Low
- LRMR $1.61
- MUE $8.53
- 52 Week High
- LRMR $11.20
- MUE $10.17
- Technical
- Relative Strength Index (RSI)
- LRMR 54.85
- MUE 40.72
- Support Level
- LRMR $1.80
- MUE $9.45
- Resistance Level
- LRMR $2.33
- MUE $9.66
- Average True Range (ATR)
- LRMR 0.18
- MUE 0.11
- MACD
- LRMR 0.04
- MUE -0.01
- Stochastic Oscillator
- LRMR 90.00
- MUE 19.47
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About MUE Blackrock MuniHoldings Quality Fund II Inc.
BlackRock MuniHoldings Quality Fund II Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. The fund seeks to achieve its investment objective by investing in long-term, investment-grade municipal obligations exempt from U.S. federal income taxes.